Table 3 Multivariate regression adjusted total cost of treatment by provider setting, 2002 $ USD (N=145)
Inpatient | Outpatient | Prescription medication | Overall | |
|---|---|---|---|---|
Type of infection | ||||
Non MDR-TB | Ref. | Ref. | Ref. | Ref. |
MDR-TB | $18,729 (15,563, 21,893) *** | $592 (−192, 1,375) | $2,199 (1,956, 2,442)*** | $21,520 (18,751, 24,288)*** |
Sex | ||||
Female | Ref. | Ref. | Ref. | Ref. |
Male | $5,002 (1,362, 8,641) ** | -$834 (1,859, 191) | $228 (−41, 497) | $4,395 (1,358, 7,433)** |
Age group | ||||
<25 | Ref. | Ref. | Ref. | Ref. |
25-64 | $4,310 (−1,294, 9,914) | -$436 (−1,781, 909) | $224 (−214, 661) | $4,097 (−987, 9,181) |
>=65 | $6,244 (−993, 13,480) | -$1,233 (−2,666, 199) | 30 (−517, 577) | $5,040 (−1,738, 11,818) |
Outcome of treatment | ||||
Not cured | Ref. | Ref. | Ref. | Ref. |
Cured | $7,707 (3,044, 12,371)*** | $1,305 (328, 2,282) ** | $923 (530, 1,315)*** | $9,935 (5,370, 14,500)*** |
Vital status | ||||
Alive | Ref. | Ref. | Ref. | Ref. |
Dead | -$4,070 (−12,424, 4,283) | -$124 (−1,105, 857) | -$65 (−919, 788) | -$4,259 (−13,215, 4,696) |
R2 | .51 | .10 | .67 | .63 |
N | 145 | 145 | 145 | 145 |